# Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia

> **NCT01105273** · PHASE1,PHASE2 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Aplastic Anemia

## Interventions

- **BIOLOGICAL:** anti-thymocyte globulin
- **BIOLOGICAL:** filgrastim
- **DRUG:** Fludarabine
- **DRUG:** Cyclophosphamide
- **PROCEDURE:** CD3±CD19 depleted hematopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT01105273
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01105273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01105273, "Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT01105273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*